Log In
Print
BCIQ
Print
Print this Print this
 

levotofisopam (S-tofisopam)

  Manage Alerts
Collapse Summary General Information
Company Pharmos Corp.
DescriptionS-entantiomer of racemic tofisopam
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia and gout
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today